GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (FRA:D4S) » Definitions » Other Current Payables

Daiichinkyo Co (FRA:D4S) Other Current Payables : €-0 Mil (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co Other Current Payables?

Daiichinkyo Co's Other Current Payables for the quarter that ended in Mar. 2024 was €-0 Mil.

Daiichinkyo Co's quarterly Other Current Payables increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€0 Mil) but then declined from Dec. 2023 (€0 Mil) to Mar. 2024 (€-0 Mil).

Daiichinkyo Co's annual Other Current Payables stayed the same from Mar. 2022 (€0 Mil) to Mar. 2023 (€0 Mil) but then declined from Mar. 2023 (€0 Mil) to Mar. 2024 (€-0 Mil).


Daiichinkyo Co Other Current Payables Historical Data

The historical data trend for Daiichinkyo Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co Other Current Payables Chart

Daiichinkyo Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Daiichinkyo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Daiichinkyo Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Daiichinkyo Co Other Current Payables Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiichinkyo Co (FRA:D4S) Business Description

Traded in Other Exchanges
Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first U.S approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co (FRA:D4S) Headlines

No Headlines